A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of V158866 in Healthy Volunteers

Trial Profile

A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of V158866 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2016

At a glance

  • Drugs V 158866 (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Vernalis
  • Most Recent Events

    • 17 Mar 2016 Results published in the Drugs in R and D
    • 31 Aug 2012 Results presented at the 14th World Congress on Pain.
    • 23 Aug 2012 Results were presented at the World Congress on Pain (August 2012)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top